| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/24/2002 | US6455670 Peptide for use in the treatment and prevention of viral diseases |
| 09/24/2002 | US6455669 Glycoprotein for use in the treatment and prevention of bacterial infections |
| 09/24/2002 | US6455668 Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455569 Connective tissue softening |
| 09/24/2002 | US6455564 Oral administration of (5r)-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinolin-2( '1h)-one or -thione |
| 09/24/2002 | US6455518 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 09/24/2002 | US6455501 Wound healing compositions |
| 09/24/2002 | US6455500 Radiation therapy methods |
| 09/24/2002 | US6455499 Methods for treating disorders associated with LHRH activity |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455497 Methods and materials for treating inflammatory diseases |
| 09/24/2002 | US6455494 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455308 Antisense modulation of serum amyloid A4 expression |
| 09/24/2002 | US6455307 Nucleotide and amino acid sequences; for gene expression inhibition; treatment of related disorders such as alzheimer's disease; anticarcinogenic agents |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455282 Expression vector which encodes the two subunits of thyroid stimulating hormone with each under control of a separate promoter; for balanced production of alpha and beta subunits |
| 09/24/2002 | US6455281 Nucleic acids for identifying anti-fungal agents, and uses related thereto |
| 09/24/2002 | US6455280 Amino acid sequence of polypeptide involved in apoptosis; anticarcinogenic agents; antitumor agents |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455269 Method for localized administration of fibrinolytic metalloproteinases |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 09/24/2002 | US6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents |
| 09/24/2002 | US6455088 Peptide/lipid complex formation by co-lyophilization |
| 09/24/2002 | US6455074 Methods of forming and using the device for the sustained release of an active agent. the improved method of the invention for forming a polymer-based sustained release device comprises forming a polymer/active agent solution by mixing a |
| 09/24/2002 | US6455051 Ameliorant for hepatitis C therapeutic effect and application thereof |
| 09/24/2002 | US6455048 Immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases. administering a complex of heat shock protein |
| 09/24/2002 | US6455045 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455043 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 09/24/2002 | US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin |
| 09/24/2002 | US6455041 Immunogenic epitopes of the human zona pellucida protein (ZP1) |
| 09/24/2002 | US6455040 Sometimes referred to as ?tnfr-5? or ?tr5,? and now referred to hereinafter as ?trail receptor without intracellular domain? or ?trid.? |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | US6455035 Antiinflammatory; inhibiting vascular permeability and/or plasma leakage; tie-2 receptor activator, angiogenesis factor |
| 09/24/2002 | US6455025 Polysaccharide-peptide derivatives |
| 09/24/2002 | US6454787 Can withstand elevated temperatures and do not require refrigeration; |
| 09/24/2002 | CA2213302C Method of preventing or treating alimentary tract damage due to chemotherapy or radiation |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/24/2002 | CA2063273C Surfactant compositions and methods |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002073373A2 Ensemble-based strategy for the design of protein pharmaceuticals |
| 09/19/2002 | WO2002073213A2 Assay |
| 09/19/2002 | WO2002073206A2 Metabolic phenotyping in therapy with anxiolytics |
| 09/19/2002 | WO2002073188A1 Method for generating replacement cells and/or tissues |
| 09/19/2002 | WO2002073187A1 Method for generating replacement cells and/or tissues |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072829A1 Novel g protein-coupled receptor protein and dna thereof |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072825A2 Human mrp5-like protein |
| 09/19/2002 | WO2002072824A2 Human transient receptor potential channel protein. |
| 09/19/2002 | WO2002072823A2 Human g protein-coupled receptor |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072807A2 Chimeric metal-binding peptides with nuclease activity |
| 09/19/2002 | WO2002072805A2 Thymidylate synthase |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072793A2 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072787A2 Telomerase expression repressor proteins and methods of using the same |
| 09/19/2002 | WO2002072785A2 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072771A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | WO2002072770A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072767A2 Mammalian neuralized family transcriptional regulators and uses therefor |
| 09/19/2002 | WO2002072763A2 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | WO2002072757A2 Novel proteins and nucleic acids encoding same |
| 09/19/2002 | WO2002072755A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072753A2 Thymidylate synthase peptides that bind to thymidylate synthase messenger rna |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072629A1 Immunopotentiators |
| 09/19/2002 | WO2002072628A1 Physiologically active polypeptide and polynucleotide encoding the same |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072623A1 Genes and proteins, and their use |
| 09/19/2002 | WO2002072622A2 Vaccine antigens against infection by chlamydia trachomatis |
| 09/19/2002 | WO2002072621A2 Cyclohexapeptide having antimicrobial activity |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072619A1 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE |
| 09/19/2002 | WO2002072618A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | WO2002072617A1 Thiopeptide compounds |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072612A2 Peptidic modulators of the androgen receptor |
| 09/19/2002 | WO2002072610A2 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |